Home Cart Sign in  
Chemical Structure| 69-05-6 Chemical Structure| 69-05-6

Structure of Quinacrine 2HCl
CAS No.: 69-05-6

Chemical Structure| 69-05-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Mepacrine 2HCl is an acridine-derived yellow dye, previously used in the therapy and prevention of malaria and later as an antiprotozoal and immunomodulatory agent. It's also an inhibitor of phospholipase A2.

Synonyms: Mepacrine dihydrochloride; SN-390 dihydrochloride; Quinacrine 2HCl

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Quinacrine 2HCl

CAS No. :69-05-6
Formula : C23H32Cl3N3O
M.W : 472.88
SMILES Code : CC(NC1=C(C=C(OC)C=C2)C2=NC3=CC(Cl)=CC=C31)CCCN(CC)CC.Cl.Cl
Synonyms :
Mepacrine dihydrochloride; SN-390 dihydrochloride; Quinacrine 2HCl
MDL No. :MFCD00012659
InChI Key :UDKVBVICMUEIKS-UHFFFAOYSA-N
Pubchem ID :6239

Safety of Quinacrine 2HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00574483 Renal Cell Carcinoma Phase 2 Withdrawn(reevaluation of comp... More >>ound development) Less << January 2008 United States, New York ... More >> Community Care Physicians Albany, New York, United States, 12208 United States, North Carolina ClinWorks Cancer Research Center Charlotte, North Carolina, United States, 28207 Less <<
NCT00183092 - Completed - -
NCT00183092 Creutzfeldt-Jakob Disease Phase 2 Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94143 Less <<
NCT00104663 Prion Disease Not Applicable Completed - United Kingdom ... More >> National Prion Clinic London, United Kingdom, WC1N 3BG Less <<
NCT00417274 Prostatic Cancer Phase 2 Completed - -
NCT01844076 Colorectal Adenocarcinoma Phase 1 Phase 2 Recruiting June 2020 United States, Pennsylvania ... More >> Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19011 Contact: Wafik El-Deiry    215-214-4233       Principal Investigator: Wafik S. El-Deiry, MD Less <<
NCT01839955 Recurrent Non-small Cell Lung ... More >>Cancer Stage IIIB Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer Less << Phase 1 Completed - United States, Ohio ... More >> University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Cleveland, Ohio, United States, 44106 Less <<
NCT00417274 - Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.11mL

0.42mL

0.21mL

10.57mL

2.11mL

1.06mL

21.15mL

4.23mL

2.11mL

References

 

Historical Records

Categories